Menu
Auditor
The external auditor is elected by the Annual General Meeting for a period of one year at a time. The auditors review the annual report and accounting as well as the Board’s and the CEO’s administration in accordance with an audit plan that is established together with the Board.
In connection with the audit, the auditors must report their observations to the company management and the board. At least once a year, the auditors must report their observations directly to the Board without the presence of company management. The auditors also attend the Annual General Meeting where they review their audit and their recommendations in the auditor’s report.
The company’s auditor
Since the Annual General Meeting on 23 May 2018, the company’s auditor has been the registered auditing company KPMG AB, which was also re-elected at the Annual General Meeting on 12 May 2022 with the authorized public accountant Jonas Nihlberg as principal auditor, for the period until the next Annual General Meeting. The auditor has audited the annual report and consolidated accounts for the financial year 2021-01-01 to 2021-12-31 and also the quarterly report for the third quarter.
SpectraCure is developing the future systems for the treatment of internal solid cancer tumours. The goal of the proprietary and patented treatment system is to eliminate deep-seated cancer tumours and prolong the survival of cancer patients while maintaining their quality of life. When prostate cancer recurs, there are often no established treatment options other than lifelong hormone therapy, with its associated side effects.